Evidence map›Paper›PMID 40033309›Full record

ArticleInternational breastfeeding journal2025

Call to include breastfeeding as a synergistic approach to vaccines for prevention of respiratory syncytial virus disease.

Laura Fischer, Elochukwu Okanmelu, Melissa Ann Theurich

Abstract read
In one paragraph

Article in International breastfeeding journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. [Research advances in non-pharmacological interventions in pediatric asthma].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura FischerChair of Public Health and Health Services Research, Institute for Biostatistics, Epidemiology, Medical Information Processing, Medical Faculty, Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany.
Elochukwu OkanmeluChair of Public Health and Health Services Research, Institute for Biostatistics, Epidemiology, Medical Information Processing, Medical Faculty, Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany.
Melissa Ann TheurichChair of Public Health and Health Services Research, Institute for Biostatistics, Epidemiology, Medical Information Processing, Medical Faculty, Ludwig-Maximilians-Universität München (LMU Munich), Munich, Germany. melissa.theurich@lmu.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfections with respiratory syncytial virus (RSV) in infancy and early childhood are very common. RSV is the leading cause of bronchiolitis and pneumonia and substantially contributes to the morbidity and mortality of infants and young children worldwide. Until very recently, there have been no vaccines available for prevention and there are no curative treatments for RSV. Two novel pharmaceutical approaches for RSV prevention became available in 2024 namely immunization of mothers during pregnancy and immunoprophylaxis of infants. Since then, a series of scientific papers as well as national and international guidance have been published to encourage parents to vaccinate themselves or their children. Despite strong evidence that breastfeeding is an important non-pharmacological approach for prevention of severe RSV outcomes, recent scientific papers and public health communications have neglected breastfeeding as a core RSV-preventive strategy. This commentary highlights epidemiological evidence of the protective effects of breastfeeding as a key non-pharmacological intervention, discussing its synergistic role in RSV prevention and supportive role in the care of sick infants. BREASTFEEDING AND RSV: Breastfeeding has been shown to reduce the rate and severity of RSV-associated outcomes, including hospitalization and mortality. While exclusive breastfeeding is most protective, even one month of breastfeeding was associated with a reduced likelihood of Intensive Care Unit admission and the need of mechanical ventilation in RSV-infected infants. The benefits of breastfeeding for RSV prevention and supportive care have been demonstrated in epidemiological studies in low-, middle- and high-income settings and are especially important for small, premature and sick infants.

conclusionBreastfeeding is an overlooked sustainable strategy for the universal prevention of severe outcomes and serves as supportive care of RSV-associated disease in infancy, especially in vulnerable population groups. Breastfeeding should be encouraged alongside vaccines in all public health communication, by health providers during pre- and postnatal immunization visits and during infant check-ups. Further, the role of breastfeeding as supportive care of RSV-infected and critically-ill infants should not be overlooked.

Indexed as

Breast FeedingRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesFemaleHumansInfantInfant, NewbornPregnancyRespiratory Syncytial Virus VaccinesBreastfeedingImmunizationLower respiratory infectionsPreventionPublic health communicationRespiratory syncytial virusRSVSupportive careVaccine

Identifiers

PMID40033309
PMCPMC11874759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.